Center for Iron Disorders
Preparation of minihepcidins for injection
Primary hepatocyte isolation
Tissue iron measurement
Dr. Leon Kautz received ASH 2014 Joanne Levy Award
Leon Kautz, PhD, received the 2014 Joanne Levy Memorial Award for Outstanding Achievement. This award is presented to the current ASH Scholar with the highest-scoring abstract for the ASH annual meeting, as determined by the appointed abstract reviewers.
The American Society of Hematology Announces 2015 Scholar Award Recipients
Joanne Levy, MD, Memorial Award for Outstanding Achievement
León Kautz, PhD, of the University of California – Los Angeles (UCLA) will receive the 2014 Joanne Levy, MD, Memorial Award for Outstanding Achievement. This award is made possible by the family of past ASH Scholar Award recipient and distinguished Society member Joanne Levy, MD, who passed away in 2004, and is presented to the current ASH Scholar with the highest-scoring abstract for the ASH annual meeting, as determined by the appointed abstract reviewers.
Dr. Kautz, who received his PhD in Molecular, Cellular, and Integrated Physiopathology from the University of Toulouse in France and is currently a postdoctoral fellow in the Department of Medicine in the Division of Pulmonary and Critical Care at UCLA, is being honored for his plenary abstract, "Role of Erythroferrone in the Pathophysiology of Common Anemia." This is the second consecutive year that Dr. Kautz has received this prestigious ASH award.
Dr. Kautz's current laboratory research focuses on erythroferrone, the erythroid factor that he and colleagues have identified as responsible for coordinating iron supply for erythropoiesis. Supported by his ASH Scholar Award, Dr. Kautz is working to identify the mechanism involved in this regulation, including the receptors for erythroferrone and the signaling pathway through which it suppresses hepcidin. Dr. Kautz and his colleagues are also investigating whether erythroferrone plays a role in inherited anemias with ineffective erythropoiesis, such as thalassemia and congenital dyserythropoietic anemia, in which low hepcidin levels contribute to the development of iron overload.
Dr. Tomas Ganz received 2014 E. Donnall Thomas Award from the American Society of Hematology
Merganser Biotech Inc. raises $28 million to develop hepcidin mimetic peptides
Dr. Tomas Ganz interviewed on Florida radio station
UCLA Pediatric Nephrology and the Center for Iron Disorders collaborate to study the regulation of iron and phosphate metabolism in chronic kidney diseases
Silarus Therapeutics is developing erythroferrone-targeting therapeutics for the treatment of iron disorders
João Arezes received the First Prize at the Department of Medicine Research Day and will present at the ASH Annual meeting
Deadly Vibrio vulnificus infection
Léon Kautz presentation at the Plenary Scientific Session of the American Society of Hematology Meetings in New Orleans.
Emilio Ramos and Tomas Ganz receive the CTSI Publication Award
Elizabeta Nemeth talks about iron overload on Univision's morning program
Tomas Ganz talks about anemia on Univision's morning program
Tomas Ganz selected to lead the UCLA Center for Accelerated Innovation
American Society of Hematology Annual Meeting, Orlando, FL, 2015
FASEB: Trace Elements in Biology and Medicine, Big Sky, MT, 2016
Cooley's Anemia Symposium, Chicago, IL, 2015
European Iron Club, Innsbruck, Austria, 2016
East-to-West Iron Club, New York City, NY, 2015
BioIron Congress, Beijing, China, 2015
Center for Iron disorders © 2012. All Rights Reserved. Designed by Veruda